Skip to search formSkip to main contentSkip to account menu

Sch 00013

Known as: SCH00013, Sch-00013 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

DihydropyridinesPyridazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Actions of a New Cardiotonic Agent, SCH00013, on Guinea-pig Heart
2016
2016
Actions of a New Cardiotonic Agent, SCH00013, on Guinea-pig Hearts
A new cardiotonic agent, SCH00013 (SCH), which was synthesized by Zenyaku Kogyo Company, Limited, exhibits cardiotonic effects by… 
2015
2015
Effect of myofilament Ca(2+) sensitivity on Ca(2+) wave propagation in rat ventricular muscle.
2014
2014
Comparative evaluation of calcium-sensitizing agents, pimobendan and SCH00013, on the myocardial function of canine pacing-induced model of heart failure.
Pimobendan and SCH00013 are calcium sensitizers that possess dual action of calcium sensitization and phosphodiesterase-III… 
Review
2006
Review
2006
Pharmacology of SCH00013: a novel Ca2+ sensitizer.
Cardiotonic agents that facilitate cardiac pump function by direct improvement of contractile dysfunction are indispensable for… 
2003
2003
Cardiotonic Agent SCH00013 Prolongs Survival of Cardiomyopathic Hamsters
&NA; The authors examined the effects of long‐term treatment with SCH00013, a novel cardiotonic agent with calcium‐sensitizing… 
1999
1999
Investigation on SCH00013, a Novel Cardiotonic Agent with Ca++ Sensitizing Action
Summary In order to clarify the mechanism of action of 4,5-dihydro-6-[1-[2-hydroxy-2-(4-cyanophenyl) ethyl]-1,2,5,6… 
1999
1999
Investigation on SCH00013, a Novel Cardiotonic Agent with Ca++ Sensitizing Action
Summary In vivo cardiovascular effects and bioavailability of 4,5-dihydro-6-[1-[2-hydroxy-2-(4-cyanophenyl)ethyl]-l,2,5,6… 
1999
1999
Investigation on SCH00013, a Novel Cardiotonic Agent with Ca++ Sensitizing Action
Summary The cardiovascular effects of the enantiomers, (+)-SCH00013 and (-)-SCH00013 of a novel cardiotonic agent 4,5-dihydro-6… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)